Overview
Total raised
$10M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 9, 2015 | AveXis Raises $10M in Funding | AveXis, a Dallas, Texas-based gene therapy-focused biotech company, raised $10m in funding. The round was led by Deerfield Management and Roche Venture Fund. In conjunction with the funding, Jonathan Leff of Deerfield and Carole Nuechterlei... |
| Apr 25, 2014 | Gene therapy for spinal muscular atrophy secures funding to begin clinical trials | The company’s approach is to deliver functioning copies of the SMN gene to cells so they can produce adequate SMN proteins. It does that using a viral vector licensed from the company ReGenX. The upcoming trial will enroll nine infants with... |
| Gene therapy for spinal muscular atrophy secures funding to begin clinical trials | A Dallas biotech startup has raised money to begin clinical trials for what it hopes could be a treatment for the top genetic cause of infant mortality. AveXis is developing a viral gene therapy for infants with spinal muscular atrophy. Wit... |
Reviews 0
FAQ about AveXis
How much funding has AveXis raised?
AveXis has raised $10M in total across 1 funding round.
What has the press written about AveXis?
Parsers VC has collected 4 articles mentioning AveXis, among them “AveXis Raises $10M in Funding” (Jan 9, 2015) and “Gene therapy for spinal muscular atrophy secures funding to begin clinical trials” (Apr 25, 2014).
Is AveXis still active?
AveXis is probably closed: its latest activity on Parsers VC dates from Jan 12, 2015.